Looks like the shorts know the end is near. This is a NOTHING BURGER.
Won't be the first not for profit organization that is trying to sabotage Leronlimab or smear CytoDyn. Just look at who bought out our former CRO. Coincidence that our CRO is bought out by a not for profit and we suddenly no longer are being given trial data and that we find out 4+ years later we had 5 patients that had an amazing response.
I have high confidence that Sidley Austin would be brought in to deal with whomever is behind this if it ever becomes necessary.
Remember the Activist Group. They were backed by "Dark Money":
CytoDyn Inc.
Soliciting Materials filed pursuant to Rule 14a-12 on August 19, 2021
File No. 000-49908
• “ The Group’s new disclosures reveal the “dark money” funding its hostile takeover attempt.”
Response:
Prior to the start of the Federal Court Litigation, the Activist Group only disclosed that the proxy
contest solicitation expenses will be financed by CCTV, an entity about which nothing was publicly
known. Following the filing of the Complaint, the Activist Group amended its preliminary proxy
statement to name the Company shareholders that gifted money to CCTV (the “Gifting Persons”).
Even in this updated disclosure, certain of the Gifting Persons that are named are non-public entities
whose owners and financial backers remain unknown.
The term “dark money” is commonly utilized to refer to anonymous election campaign contributions
made by donors whose individual identities are not disclosed. This is directly applicable to the
anonymous financial contributions made to CCTV for the purpose of financing the Activist Group’s
director election contest. We believe shareholders deserve to know which individuals are the Activist
Group’s campaign, so that they can properly assess such individuals’ motivations in the context of the
upcoming director election.
We refer the Staff to the Complaint and the Answering Brief for more details as well as the Court
Order and the Stipulated Order.
That did not end well for the dark side.